Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country

2010 ◽  
Vol 51 (10) ◽  
pp. 1850-1854 ◽  
Author(s):  
Kunjahari Medhi ◽  
Vinod Raina ◽  
Lalit Kumar ◽  
Atul Sharma ◽  
Sameer Bakhshi ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Imatinib Mesylate ◽  
Developing Country ◽  
Myeloid Leukemia ◽  
Response Assessment ◽  
Single Center

Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country

2008 ◽  
Vol 49 (3) ◽  
pp. 554-558 ◽  
Author(s):  
Senthil Rajappa ◽  
Lalit Varadpande ◽  
Tara Paul ◽  
Rachel Jacob ◽  
Raghunadharao Digumarti
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Imatinib Mesylate ◽  
Developing Country ◽  
Myeloid Leukemia ◽  
Chronic Phase

Molecular response assessment at 3 months time point is better in late chronic phase chronic myeloid leukemia patients

2015 ◽  
Vol 15 ◽  
pp. S214
Author(s):  
Pankaj Malhotra ◽  
Santosh Chikkodi ◽  
Shano Naseem ◽  
Alka Khadwal ◽  
Gaurav Prakash ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Response Assessment ◽  
Molecular Response ◽  
Time Point
Sign in / Sign up

Export Citation Format

Share Document